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The amino acid sequence of heat-stable nterotoxin, produced by Vibrio cholerae non-01 and isolated from 
its culture su~rnatant, was determined by both Edman degradation of native and reductively carboxy- 
methylated enterotoxin and also a combination of fast atom bombardment mass spectrometry and carboxy- 
peptidase Y digestion of native enterotoxin to be as follows: Ile-Asp-Cys-Cys-Glu-Ile-Cys-Cys-Asn-Pro- 
Ala-Cys-Phe-Gly-Cys-Leu-Asn. This sequence is very similar, but not identical, to those of heat-stable nte- 
rotoxins produced by enterotoxigenic Escherichia coli and Yersinia enterocolitica. 
(Vibrio cholerae non-01) heat-stability Enterotoxin Primary str~eture 
1. INTRODUCTION 
Vibrio cholerae non-01, also named non- 
agglutinating (NAG) or non-cholera vibrios 
(NCV), sometimes causes severe gastroenteritis in 
humans, which cannot be distinguished clinically 
from cholera, but the mechanism of its 
pathogenesis is still unknown [I]. Recently, many 
investigators have tried to isolate a virulence fac- 
tor(s) related to this pathogenesis. Results have 
suggested that a cholera-like enterotoxin [2-5] and 
a heat-labile enterotoxin distinct from cholera 
enterotoxin [6,7] are produced by some strains of 
k: cholerae non-01 isolated from human patients 
and the environment. Moreover, a heat-stable 
enterotoxin (ST) similar to that of enterotoxigenic 
Escherichia coli was found to be produced by 2 
strains of I’. choierae non-01 isolated from pa- 
tients with diarrhea [8]. Very recently, some of us 
[9] succeeded in isolating a pure toxin from a strain 
(no.A-5) of t: cholerae non-01 that showed 
* To whom correspondence shouId be addressed 
similar, but not identical, physicochemical and im- 
munological properties to those of an ST of 
enterotoxigenic E. coli. These findings indicate 
that the toxin (named NAG-ST) has a similar 
structure to the STs of enterotoxigenic E. coli 
[ 10,l l] and Yersinia enterocofitica [ 12,131. Thus, it 
seemed interesting to determine the molecular 
structure of NAG-ST and to elucidate the struc- 
tural, biological and immunological relation of 
NAG-ST and other STs. 
This paper reports the amino acid sequence of 
NAG-ST produced by a strain (no.A-5) of I’. 
cholerae non-01. The sequence is very similar to 
those of enterotoxigenic E. co/i and Y. 
enterocolitica, suggesting that these STs are de- 
rived from a common ancestral transposon gene 
and form an ST-family like the cholera enterotoxin 
family [ 141. 
2. MATERIALS AND METHODS 
2.1. Isolation of toxin 
The toxin was isolated from the culture superna- 
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tant of a strain (no.A-5) of I/. cholerue non-01, as 
described [9]. The purity of the isolated toxin was 
checked by reversed-phase HPLC under the condi- 
tions in [12]. 
2.2. Amino acid analysis 
The purified toxin and its reduced and carbox- 
ymethylated derivative were hydrolyzed in 4 M 
methanesulfonic acid for 24 h at 110°C in vacua in 
sealed tubes and the hydrolysates analyzed in a 
Hitachi type 835 amino acid analyzer. 
2.3. Reductive carboxymethylation 
A sample of native toxin (- 100 pg) was reduced 
and carboxymethylated as in [lo]. Carbox- 
ymethylated toxin was recovered in a yield of 
about 40% by reversed-phase HPLC, as described 
below. 
2.4. Edman degradation 
Native toxin (- 12 nmol) was manually degraded 
by the Edman method [15]. The carbox- 
ymethylated toxin (2.45 nmol) was degraded se- 
quentially with an Applied Biosystems model 470A 
gas-phase sequenator (California), as described 
[16]. The resulting Pth-amino acids were analyzed 
by HPLC as described below. 
2.5. Carboxypeptidase Y digestion 
Two samples of native toxin of 1.07 and 
2.24 nmol, respectively, were digested with car- 
boxypeptidase Y (0.1 and 1.2 pg, Oriental, Osaka) 
at 37°C for 90 min and 15 h in 0.1 M pyridinium 
acetate (10~1) at pH 7.0. Part of the digest of the 
1.07 nmol sample was subjected to FAB mass 
spectrometry and the remainder digested further 
with carboxypeptidase B (Boehringer), as de- 
scribed [ 171, and subjected to FAB mass spectrom- 
etry. The digest of the 2.24 nmol sample was sub- 
jected to amino acid analysis, as described above. 
2.6. Fast atom bombardment (FAB) mass 
spectrometry 
FAB mass spectra were recorded with a Jeol 
double-focusing mass spectrometer, JMS-HXlOO, 
fitted with a 2.33 T magnet, an FAB ion source 
and a post-accelerating system. A Jeol DA-5000 
mass data analysis system was used for acquisition 
of mass spectra. Sample peptides (0. l-l .O nmol) 
were applied to a stainless-steel sample holder and 
xenon gas was used as a neutral atom beam. 
Typical experimental conditions were as described 
[181. 
2.7. High-performance liquid chromatography 
(HPLC) 
For purification of native and carbox- 
ymethylated toxins, a Hitachi 655 liquid 
chromatograph (Tokyo) and a column (4 x 
250 mm) of YMC-ODS (S-5, Yamamura, Kyoto) 
were used. The column was equilibrated with 10% 
CH&N in 0.05% trifluoroacetic acid (pH 2.35) 
and developed with a linear gradient of lo-40% 
CH&N. Pth-amino acids were identified using a 
Varian HPLC apparatus (Vista 5500) and a Varian 
micropack SP-ODS column (4.6 x 150 mm). 
3. RESULTS AND DISCUSSION 
The amino acid compositions of native and 
reductively carboxymethylated (CM) NAG-ST 
(fig.1) are shown in table 1. The I%& of NAG-ST 
was determined to be 1813.6 by measurements of 
the native and CM NAG-STs by FAB mass spec- 
trometry, which gave intense signals at m/z = 
1814.6 (fig.2) and 2168.6, respectively. The results 
clearly indicated that NAG-ST contains 6 half- 
cystine residues, which are intramolecularly linked 
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Fig. 1. Reversed-phase HPLC of reductively car- 
boxymethylated enterotoxin. Chromatographic on- 
ditions were as described in section 2. 
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Table 1 
Amino acid composition of the purified enterotoxin 
CM-Cys 
Asp 
Ser 
CilU 
Gly 
Ala 
1% cys 
Val 
Ile 
Leu 
T yr 
Phe 
Arg 
Pro 
Native Carboxy- Nearest 
methylated integer 
- 6.28 
3.20 3.10 3 
0.12 0.05 
1.20 1.08 1 
1.11 1.14 1 
1.00 1.00 1 
5.10 0.07 6 
0.04 - 
1.82 1.84 2 
1.11 1.02 1 
0.05 - 
1.17 1.03 1 
- 0.10 
0.83 1.05 1 
Total 17 
Values were calculated as mol/mol Ala 
by 3 disulfide bonds, and that 2 of 5 carboxyl 
groups of 3 Asp, 1 Glu and the C-terminus are pre- 
sent as amides. 
For determination of the amino acid sequence of 
NAG-ST, the ST was subjected to direct Edman 
degradation and Ile and Asp were found in posi- 
tions 1 and 2, respectively, from the N-terminus. 
The C-terminal amino acid residue of NAG-ST 
was examined by measurement [19] of the FAB 
mass spectra of the carboxypeptidase Y and B 
digests of native NAG-ST, as shown in fig.3. The 
differences between the mass values of native 
NAG-ST and the digests suggested that the C- 
terminal sequence was Leu (or Ile)-Asn. Moreover, 
native NAG-ST (2.24 nmol) released Asn 
(2.14 nmol) on amino acid analysis after digestion 
with carboxypeptidase Y. Thus, the C-terminal 
amino acid residue was concluded to be Asn. 
Thereafter, CM-NAG-ST was analyzed in a gas- 
phase sequenator. As shown in fig.4, the CM toxin 
had a sequence of 17 amino acid residues from the 
N-terminus. This finding was supported not only 
by the amino acid composition and M, values of 
the native and CM NAG-STs, but also by the mass 
values of fragment ion signals of CM-NAG-ST on 
FAB mass spectra (not shown). The sequence of 
NAG-ST thus determined was compared with 
those of enterotoxigenic E. coli and Y. 
enterocolitica. Except for Ile at position 6 and Phe 
at position 13, the sequence from position 3 to 
position 15 (core structure) was the same as those 
of the enterotoxins of E. coli and Y. enterocolitica, 
which is known to be the essential structure for ex- 
pression of full enterotoxigenic activity [17]. This 
difference in the core structures and N- and C- 
terminal sequences may be responsible for the dif- 
ferences in degrees of immunological and 
biological activities: the minimum effective dose of 
NAG-ST is 5 ng [9], which is higher than that of 
enterotoxigenic E. coli. The presence of 6 half- 
cystine residues in the same positions as in the STs 
of E. coli and Y. enterocolitica strongly indicates 
that NAG-ST has the same secondary structure as 
these STs, although the positions of disulfide 
T 
Fig.2. FAB mass spectrum of native enterotoxin. 
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Fig.3. FAB mass spectra of: (A) a digest of native enterotoxin with carboxypeptidase Y at 37°C for 90 min and (B) 
a digest of (A) with carboxypeptidase B at 37°C for 20 h. 
Vibrio cholerae non-01 ST 
1 5 10 15 
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Escherichia coli STha) NSSNYCCELCCWPACTGCY 
Escherlchia coli STpbl NTFYCCELCCNPACAGCV 
V~rS~nfa efltWOCOl ltica STCJ ~A~(X)~~~~~~AEV~S~~O~CDVCCNPACAG~ 
Fig.4. Comparison of amino acid sequence of the heat-stable enterotoxin (NAG-ST) of Fibrio cholerae non-01 with 
those of enterotoxigenic E. coli and Y. enterocolitica heat-stable nterotoxins: ( d) residues determined by Edman 
degradation of native NAG-ST; (+- and -) residues determined by FAB mass measurement and amino acid analysis 
of a CPase digest of native NAG-ST, respectively; (-_) residues determined by Edman degradation of CM-NAG-ST; 
a see [lo]; b see [ll]; ‘see [12,13]. 
linkages are still unknown, and that the tertiary 
structure formed by these 6 half-cystine residues is 
responsible for heat stability. The present results 
suggest that structurally, functionally, and im- 
munologically related heat-stable enterotoxins are 
present widely in enteric bacteria like the heat- 
labile enterotoxins produced by V. cholerae and 
enterotoxigenic E. coli. 
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